gps topical anesthetic

Generic: benzocaine

Labeler: group practice solutions, inc.
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name gps topical anesthetic
Generic Name benzocaine
Labeler group practice solutions, inc.
Dosage Form GEL
Routes
DENTAL
Active Ingredients

benzocaine 200 mg/g

Manufacturer
Group Practice Solutions, Inc.

Identifiers & Regulatory

Product NDC 69004-003
Product ID 69004-003_2b4cb1cb-60b6-26c7-e063-6394a90a10e0
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M022
Listing Expiration 2026-12-31
Marketing Start 2013-07-01

Pharmacologic Class

Established (EPC)
standardized chemical allergen [epc]
Chemical Structure
allergens [cs]
Physiologic Effect
increased histamine release [pe] cell-mediated immunity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 69004003
Hyphenated Format 69004-003

Supplemental Identifiers

RxCUI
238910
UNII
U3RSY48JW5
NUI
N0000185508 N0000175629 N0000184306 M0000728

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name gps topical anesthetic (source: ndc)
Generic Name benzocaine (source: ndc)
Application Number M022 (source: ndc)
Routes
DENTAL
source: ndc

Resolved Composition

Strengths
  • 200 mg/g
source: ndc
Packaging
  • 30 g in 1 JAR (69004-003-30)
source: ndc

Packages (1)

Ingredients (1)

benzocaine (200 mg/g)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["DENTAL"], "spl_id": "2b4cb1cb-60b6-26c7-e063-6394a90a10e0", "openfda": {"nui": ["N0000185508", "N0000175629", "N0000184306", "M0000728"], "unii": ["U3RSY48JW5"], "rxcui": ["238910"], "spl_set_id": ["69271b7a-18c0-4445-8164-cb1620fb5475"], "pharm_class_cs": ["Allergens [CS]"], "pharm_class_pe": ["Increased Histamine Release [PE]", "Cell-mediated Immunity [PE]"], "pharm_class_epc": ["Standardized Chemical Allergen [EPC]"], "manufacturer_name": ["Group Practice Solutions, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 g in 1 JAR (69004-003-30)", "package_ndc": "69004-003-30", "marketing_start_date": "20181101"}], "brand_name": "GPS Topical Anesthetic", "product_id": "69004-003_2b4cb1cb-60b6-26c7-e063-6394a90a10e0", "dosage_form": "GEL", "pharm_class": ["Allergens [CS]", "Cell-mediated Immunity [PE]", "Increased Histamine Release [PE]", "Standardized Chemical Allergen [EPC]"], "product_ndc": "69004-003", "generic_name": "Benzocaine", "labeler_name": "Group Practice Solutions, Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "GPS Topical Anesthetic", "active_ingredients": [{"name": "BENZOCAINE", "strength": "200 mg/g"}], "application_number": "M022", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20130701", "listing_expiration_date": "20261231"}